Molecular Tumor Board Guides Successful Treatment of a Rare, Locally Aggressive, Uterine Mesenchymal Neoplasm
- 1 February 2021
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 5 (5), 333-339
- https://doi.org/10.1200/po.20.00189
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumorsCurrent Opinion in Oncology, 2012
- Crizotinib inALK-Rearranged Inflammatory Myofibroblastic TumorThe New England Journal of Medicine, 2010
- LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndromeLeukemia, 2009
- Inflammatory Myofibroblastic TumorThe American Journal of Surgical Pathology, 2007
- Inflammatory Myofibroblastic Tumor of the UterusThe American Journal of Surgical Pathology, 2005
- GCF2/LRRFIP1 Represses Tumor Necrosis Factor Alpha ExpressionMolecular and Cellular Biology, 2005
- Anaplastic Lymphoma Kinase (ALK) Expression in the Inflammatory Myofibroblastic TumorThe American Journal of Surgical Pathology, 2001
- ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic TumorLaboratory Investigation, 2001
- TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic TumorsThe American Journal of Pathology, 2000
- Extrapulmonary Inflammatory Myofibroblastic Tumor (Inflammatory Pseudotumor) A Clinicopathologic and Immunohistochemical Study of 84 CasesThe American Journal of Surgical Pathology, 1995